Fair Value (Details) (USD $) | 9 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2011
Medfusion Rx [Member] | Dec. 28, 2010
Medfusion Rx [Member] | Sep. 30, 2011
Medfusion Rx [Member]
Fair Value, Measurements, Recurring [Member]
Fair Value, Inputs, Level 3 [Member] | Sep. 30, 2011
Fair Value, Measurements, Recurring [Member]
Fair Value, Inputs, Level 1 [Member] | Dec. 31, 2010
Fair Value, Measurements, Recurring [Member]
Fair Value, Inputs, Level 1 [Member] | Sep. 30, 2011
Fair Value, Measurements, Recurring [Member]
Fair Value, Inputs, Level 2 [Member] | Dec. 31, 2010
Fair Value, Measurements, Recurring [Member]
Fair Value, Inputs, Level 2 [Member] | Dec. 31, 2010
Fair Value, Measurements, Recurring [Member]
Fair Value, Inputs, Level 3 [Member] | Sep. 30, 2011
Fair Value, Measurements, Recurring [Member]
Estimate of Fair Value, Fair Value Disclosure [Member] | Dec. 31, 2010
Fair Value, Measurements, Recurring [Member]
Estimate of Fair Value, Fair Value Disclosure [Member] | |
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||||||
| Derivatives | $ 0 | $ 274,000 | $ 0 | $ 0 | $ 274,000 | |||||
| Contingent purchase price consideration | 4,865,000 | 5,060,000 | 0 | 0 | 0 | 0 | 4,865,000 | 5,060,000 | 4,865,000 | |
| Contingent consideration, cash, based on 2012 performance target | 5,500,000 | |||||||||
| Contingent consideration, change in value of contingent purchase price | $ 195,000 | |||||||||